Publication details

Okrelizumab v rozdílných indikacích

Title in English Okrelizumab in different indications
Authors

ŠROTOVÁ Iva HLADÍKOVÁ Magdaléna KOLČAVA Jan ŠTOURAČ Pavel PETRÁŠOVÁ Martina

Year of publication 2023
Type Article in Periodical
Magazine / Source Multiple sclerosis News
MU Faculty or unit

Faculty of Medicine

Citation
Web https://www.worldmednet.cz/okrelizumab-v-rozdilnych-indikacich/
Keywords Okrelizumab; multiple sclerosis
Description Multiple sclerosis (MS) is a chronic, immune-mediated neurological disease of the central nervous system. The inflammatory process and inflammation-triggered neurodegeneration play an important role in the pathogenesis of the disease. B-lymphocytes are thought to be the key factors responsible for tissue involvement. In recent years, attention has therefore focused on the development of anti-CD20 monoclonal antibodies that selectively deplete B-cells.

You are running an old browser version. We recommend updating your browser to its latest version.

More info